Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

RESEARCH & DEVELOPMENT SUPPORT SERVICES

Active

Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Naval Medical Research Center, under the Department of the Navy, has issued a forecast for Research and Development Support Services. This requirement is categorized under NAICS code 541714, indicating a focus on research and development in the physical, engineering, and life sciences. The performance of these services is expected to take place in Virginia. Interested parties can find further information through the Secretary of the Navy's small business portal.

General Info

Navy NMRC seeks R&D support services in Virginia under NAICS code 541714.

Agency

Department Of The Navy → Naval Medical Research CenterView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

VA, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 2

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of The Navy → Naval Medical Research Center

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of The Navy → Naval Medical Research Center

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

RESEARCH & DEVELOPMENT SUPPORT SERVICES

Similar Contracts

Same NAICS industry code

Bridge Contract - Disease Surveillance and Research Support

Solicitation # PANDHA-26-P-0000-047373

Defense Health Agency

POSTED

DEADLINE

Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70

Solicitation # 75N98026Q00996

The National Cancer Institute intends to award a sole-source, firm fixed price contract under solicitation RFQ 75N98026Q00996 to the Viral Vector Core at the Pandemic Institute, University of Oxford. The project involves the design and production of ChAdOx-1 and MVA viral vectors expressing mouse gp70 and the mouse class II major histocompatibility complex invariant chain. This research is critical for evaluating vaccine efficacy against breast cancer brain metastasis, utilizing proprietary chimpanzee adenovirus technology to avoid pre-existing human adenovirus immunity. The contract falls under NAICS code 541714 for biotechnology research and development and has a performance period of six months from the date of award. Payment terms are set at net 30 days following the acceptance of deliverables. While intended as a sole-source procurement due to the proprietary nature of the technology, the agency will consider capability statements from other interested parties submitted by August 24, 2026.

POSTED

DEADLINE

in about 18 hours

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Solicitation # W911SR-26-R-HEAL

The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.

POSTED

DEADLINE

Skin commensal sequencing

Solicitation # 75N98026Q01038

The National Institutes of Health intends to award a non-competitive contract for skin commensal sequencing to SeqCoast Genomic LLC. This procurement, identified by synopsis number 75N98026Q01038, falls under NAICS code 541714 and is being conducted via Simplified Acquisition Procedures for an amount not exceeding 350,000 dollars. The project supports the laboratory of Julie Segre in studying the human skin microbiome by extracting and sequencing genomes of skin commensal organisms to streamline workflows and reduce costs for ongoing research. Interested parties must submit their capabilities, including a technical and cost-price proposal, by August 31, 2026, at 9:00 AM Eastern time. All submissions must be sent electronically to the contracting officer and require an active registration in the System for Award Management. While the government intends to proceed on a non-competitive basis, it will review submitted capability statements to determine if a competitive procurement is necessary.

National Institutes Of Health Olao

POSTED

DEADLINE

Nanobody against NPR-C for growth disorder

Solicitation # 75N98026Q01031

This project focuses on the development of high-affinity and specific VHH nanobodies against human NPR-C to create potential therapeutics for growth disorders like achondroplasia. The scope of work involves two possible development tracks: phage/yeast display using immunized libraries or single B-cell cloning. The process includes antigen generation, alpaca or llama immunization, library construction or B-cell isolation, and rigorous screening and sequencing to identify unique clones. The final goal is to produce and characterize at least 10 unique VHH-Fc candidates with a target affinity of KD=10nM or better, ensuring no cross-reactivity with NPR-B. The project is expected to be completed within four to six months, with deliverables including serum titer reports, sequence data, purified antibodies, and a final summary report. The NIH retains all intellectual property ownership of the resulting antibodies and data. Out of scope activities include humanization, affinity maturation, GMP manufacturing, and stable cell line development. The contract follows a milestone-based payout structure and requires vendors to comply with IACUC-equivalent animal welfare standards.

National Institutes Of Health Olao

POSTED

DEADLINE

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

BARDA is seeking contractors to support the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The selected providers will be responsible for furnishing all necessary personnel, materials, and facilities to produce vaccines, antigens, and adjuvants for pandemic preparedness and public health emergencies. This includes generating and submitting critical analytical, clinical, and manufacturing data to the FDA to ensure rapid regulatory decisions and manufacturing readiness. To be eligible for this award, offerors must have experience producing vaccines against influenza and strains with pandemic potential. Mandatory qualifications include either holding a U.S. influenza vaccine license or demonstrating the development of an influenza vaccine through the submission of a Biologics License Application for seasonal or pandemic vaccines. This solicitation is managed by the Department of Health and Human Services with a response deadline of October 30, 2026.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Pre-solicitation Notice: On-Ramp for the Department of Defense OMNIBUS IV Multiple-Award Contract

Solicitation # HT942626RE002

The Defense Health Agency Contracting Activity is preparing to issue an on-ramp to the OMNIBUS IV Multiple Award, Indefinite Delivery, Indefinite Quantity contract vehicle, which supports military medical research and development services across four distinct market segments: medical research and development support, general research and development support, regulatory processes for human and animal research, and translational science services for moving innovations from laboratory to clinical practice. This on-ramp opportunity is exclusively set-aside for small businesses certified under the Small Business Administration’s 8(a) Program, with the aim of expanding the pool of qualified contractors while maintaining alignment with the existing unrestricted contract vehicle. The OMNIBUS IV IDIQ has a cumulative ceiling of $10 billion and has already generated over $600 million in task order awards across 51 task orders since its base period began in 2022, with the majority of activity occurring in fiscal years 2024 through 2026. Task orders are competitively awarded, including set-asides for 8(a) participants, and may be issued by various DoD entities including DHACA, the Naval Supply Systems Command, and the Uniformed Services University of the Health Sciences. The upcoming solicitation, expected to be posted on SAM.gov in late February 2026, follows a delay to align with the February 2026 implementation of the FAR Overhaul, which significantly impacts how small business status is handled under unrestricted IDIQ contracts. Under the new rules, contractors do not need to recertify their small business status at the task order level when bidding on 8(a)-set-aside work, as they may rely on their original IDIQ-level size and status representation—even if they have graduated from the 8(a) Program or grown beyond small business size thresholds. However, contractors must still recertify their status at the IDIQ level within 60 to 120 days prior to the end of the fifth contract year, in compliance with FAR 19.301-2(b)(1)(iii)(A). Proposals must be submitted via the PIEE Solicitation module using a SAM.gov-registered account, and while the initial pre-solicitation notice provides the framework and intent, detailed evaluation criteria, submission instructions, and contract clauses will be formally outlined in the forthcoming RFP. All awards under this on-ramp will be made to small business 8(a) participants, and the government anticipates issuing multiple new contracts

Defense Health Agency

POSTED

DEADLINE

Core Research in Biological Sciences (BIO Core)

Solicitation # 26-517

The National Science Foundation's Directorate for Biological Sciences is offering funding through the Core Research in Biological Sciences solicitation 26-517. This opportunity supports foundational and interdisciplinary research across all biological levels, from molecular to biome scales, encompassing both legacy program topics and new areas of biological science. The program provides single- and multi-investigator awards with flexible budgets and durations to accommodate both small exploratory projects and long-term research commitments. These federal awards are subject to the availability of funds and are managed by the National Science Foundation.

National Science Foundation

POSTED

DEADLINE

in almost 50 years

On-Site Installation and Training ServicesThis subcontract opportunity with the Department of Commerce NIST involves on-site installation, calibration, and training services located in Gaithersburg, Maryland. The scope of work includes system setup and the verification of technical specifications. While these specific services are not mandatory, they will be given additional evaluation consideration if included in the proposal. The project is designated as a total Small Business Set Aside under NAICS code 541714. Interested parties must submit their responses by August 28, 2026, at 1:00 PM. The solicitation was officially posted on August 15, 2026.

Department Of Commerce Nist

POSTED

DEADLINE

Technical Readiness & Prototype DemonstrationThe Technical Readiness and Prototype Demonstration is a subcontract opportunity issued by the Department of Defense under the FA2553 Oprn Testing and Trg Infr Otti Pk agency. The primary objective of this effort is to demonstrate the technical capability to build, test, and deploy software from commercial facilities into government cloud enclaves, ensuring a secure and automated delivery process. This project falls under NAICS code 541714 and will be performed in Colorado Springs. Interested parties must submit their responses by September 4, 2026, following the posting date of August 13, 2026.

FA2553 Oprn Testing & Trg Infr Otti Pk

POSTED

DEADLINE

Established Clinician Investigator Award to Support Mentoring (KS1)The Established Clinician Investigator Award to Support Mentoring (KS1) is a forecast opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This award is designed to provide established clinician investigators with a sustained period of protected time, enabling them to deliver high-quality mentoring and guidance to early-career clinician research scientists. The program is managed by the Division of Biomedical Research Workforce, which serves as the primary point of contact for interested parties. While specific performance locations and set-aside details are not listed, the award aims to strengthen the pipeline of clinician researchers through structured mentorship support.

National Institutes Of Health

POSTED

DEADLINE

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The National Institute on Aging is issuing a forecast for the Alzheimer's Drug-Development Program to support the pre-clinical and early-stage clinical Phase I development of novel biologic and small-molecule drug candidates. The program aims to identify treatments that prevent Alzheimer's disease, slow its progression, or address cognitive and behavioral symptoms. Funding is available for academic and biotech researchers to conduct development activities internally or through specialized contract research organizations. The initiative focuses on expanding the portfolio of investigational drug candidates for emerging therapeutic targets and diversifying the therapeutic pipeline to support mono-therapy, combination therapy, and precision medicine approaches. This opportunity will utilize the U01 activity code. While applications are not currently being accepted, this notice serves to allow potential applicants time to establish collaborations and design responsive projects.

National Institutes Of Health

POSTED

DEADLINE

More opportunities from Department Of The Navy → Naval Medical Research Center

Same awarding agency

Invitrogen materials

Solicitation # BAC260021

The contract pertains to the procurement of Invitrogen materials specifically designated for use in IACUC protocol 26_01, with the required supplies including three units of the MK Cytokine 29-plex Mag Kit, one unit each of the MagPlex Calibration Kit, MagPlex Performance Verification Kit, and a four-pack of MagPlex Drive Fluid Plus. These reagents and kits are essential for multiplexed biological analysis and must be delivered to Cavalier Logistics at 45085 Old Ox Rd, Dulles, VA 20166, USA. The solicitation, identified as BAC260021, was posted on August 5, 2026, with responses due by August 19, 2026, and falls under an 8(a) Sole Source procurement as authorized under FAR 19.8, indicating it is intentionally awarded to a small disadvantaged business without competitive bidding. The contracting activity is managed by the Naval Medical Research Center under the Department of Defense, with the primary point of contact being Luciana Encinas based in Silver Spring, MD, and a secondary contact, Shamai Carter, available for coordination. The place of performance is listed as Bellavista, Callao, Peru, despite the delivery address being in Virginia, suggesting a potential discrepancy or complexity in logistics routing.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

Laboratory Instrumentation Supplies (Phoenix & MALDI Biotyper Reagents)The Naval Medical Research Center within the Department of Defense is seeking a subcontractor for the supply of OEM-compatible consumables and reagents. These materials are specifically required for automated microbial identification systems, including the Phoenix and MALDI Biotyper platforms. This opportunity is designated as an 8(a) Sole Source set-aside under NAICS code 334510. The contract was posted on August 13, 2026, with a response deadline of August 27, 2026, and the place of performance is located in Bellavista, Callao.

Electromedical and Electrotherapeutic Apparatus Manufacturing

POSTED

DEADLINE

Ultrapure Water and Reagent-Grade Chemicals SupplyThe Naval Medical Research Center under the Department of Defense is seeking a subcontractor for the supply of ultrapure water and reagent-grade saline solutions. These materials are essential for laboratory testing and preparation processes. The procurement is categorized under NAICS code 325998 and is designated as an 8(a) Sole Source set-aside. The opportunity was posted on August 13, 2026, with a response deadline of August 27, 2026. Performance of the contract is designated to take place in Bellavista, Callao 02.

All Other Miscellaneous Chemical Product and Preparation Manufacturing

POSTED

DEADLINE

Laboratory Consumables SupplyThe Naval Medical Research Center within the Department of Defense is seeking a subcontractor for the supply of general-use plastic laboratory consumables. The scope of work includes the provision of essential items such as 96-well plates, sterile transport systems, and test strips. This requirement is categorized under NAICS code 326199 and will be performed in Bellavista, Callao. This opportunity is designated as an 8(a) Sole Source set-aside under FAR 19.8. The solicitation was posted on August 13, 2026, with a response deadline set for August 27, 2026.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Molecular Diagnostic Reagent SupplyThe Naval Medical Research Center within the Department of Defense is seeking a subcontractor for the supply of RT-PCR kits and viral RNA extraction kits used for the molecular detection of enteric pathogens. This procurement is categorized under NAICS code 325414 and is designated as an 8(a) Sole Source set-aside. The contract was posted on August 13, 2026, with a response deadline of August 27, 2026. The place of performance for this requirement is located in Bellavista, Callao 02.

Biological Product (except Diagnostic) Manufacturing

POSTED

DEADLINE

Microbiology Culture Media SupplyThe Naval Medical Research Center within the Department of Defense is seeking a subcontractor for the supply of bacteriological agar and culture media. This procurement specifically focuses on materials required for the isolation of pathogens, including ETEC, Campylobacter, and Shigella. The contract is categorized under NAICS code 325212 and is designated as an 8(a) Sole Source set-aside. The opportunity was posted on August 13, 2026, with a response deadline of August 27, 2026. Performance for this contract is designated to take place in Bellavista, Callao 02.

Synthetic Rubber Manufacturing

POSTED

DEADLINE

Laboratory items

Solicitation # BAC260011_1301375341

This contract, issued by the Naval Medical Research Center under the Department of Defense, involves the procurement of specialized laboratory supplies for research tasks within the Bacteriology department. The order includes a diverse range of materials such as various agar types, culture media, RT-PCR kits, viral RNA mini kits, and essential consumables like reaction plates, transport systems, and ultrapure water. The solicitation, identified as BAC260011_1301375341, is designated as an 8(a) Sole Source set-aside under NAICS code 423450. The procurement process was posted on August 13, 2026, with a response deadline of August 27, 2026. While the contracting office is located in Silver Spring, Maryland, the place of performance is situated in Callao.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000

Solicitation # N3239826Q4072

The Department of the Naval Medical Research Command plans to award a sole source contract to Illumina Inc. for a comprehensive full-service maintenance and repair plan for the Illumina NovaSeq 6000 system, specifically unit S/N A01716. This one-year contract includes four identical Silver Support Plans tailored to this specific equipment, ensuring coverage that meets stringent manufacturer standards. Key services encompass full OEM parts replacement, labor, and travel by certified technicians, no-cost replacement of proprietary reagents lost due to hardware failure, and at least one on-site preventative maintenance visit annually that aligns with OEM requirements. Additional provisions include remote technical support available Monday through Friday from 6:00 a.m. to 6:00 p.m., on-site technician response within two business days for any hardware performance issues, and control software and hardware updates as specified by the OEM. The contract also features on-site applications support, remote monitoring, and discounted advanced training for laboratory operators. The solicitation, identified by number N3239826Q4072, is managed by the Naval Medical Research Center, based in Silver Spring, Maryland, with submission deadline set at the end of 2026. The primary contacts for this procurement are Deborah Sharpe and Stephanie Gray.

Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

Supply of OEM-Compliant Replacement Parts & ReagentsThis contract involves the supply of OEM-authorized replacement parts and reagents for the NovaSeq 6000 system, specifically including components such as flow cells and optics. It ensures the provision of reagents with a no-cost replacement policy for any lost or damaged items, while also requiring strict adherence to FDA safety updates throughout the contract term. The primary objective is to maintain the functionality and compliance of the equipment used by the Naval Medical Research Center. Issued by the Department of Defense through the Naval Medical Research Center, the subcontract focuses on maintaining essential inventory for the NovaSeq 6000 in Silver Spring, with a relevant NAICS code of 423490. The contract was posted in late December 2025, with responses due by the end of 2026, allowing adequate time for interested suppliers to submit proposals. This arrangement supports the critical biomedical research capabilities of the military medical research entity by ensuring uninterrupted access to reliable replacement parts and reagents.

Other Professional Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

On-Site Remedial Repairs & Emergency ResponseThe contract involves providing emergency on-site repair services for the NovaSeq 6000 system, ensuring that response times do not exceed two business days. The primary objective is to restore the equipment to original equipment manufacturer (OEM) operational standards using only authorized parts, guaranteeing high-quality and reliable repairs. This work is being conducted under a subcontract for the Department of Defense, specifically for the Naval Medical Research Center, with the place of performance located in Silver Spring, Maryland. The solicitation was posted on December 22, 2025, and responses are due by December 31, 2026. It falls under NAICS code 811211, which relates to equipment repair services. There are no specified set-aside requirements or organization type restrictions associated with this subcontract. The comprehensive nature of the contract emphasizes prompt emergency response and adherence to strict quality standards to maintain critical medical research operations.

Consumer Electronics Repair and Maintenance

POSTED

DEADLINE

Remote Technical Support & Monitoring ServicesThis contract entails providing remote technical support and system monitoring services for the NovaSeq 6000 system during designated business hours. The scope includes troubleshooting, performing software updates, and conducting diagnostics using secure original equipment manufacturer (OEM) tools to ensure optimal system performance. The services are aimed at maintaining the operational readiness and reliability of the equipment through proactive management and timely issue resolution. Issued by the Naval Medical Research Center under the Department of Defense, this subcontract opportunity falls under the NAICS code 541512, which pertains to computer systems design services. The place of performance is located in Silver Spring, with the deadline for responses set for December 31, 2026. This contract represents an important technical support role critical to sustaining advanced research capabilities within a government medical research environment.

Computer Systems Design Services

POSTED

DEADLINE

Quarterly On-Site Preventive Maintenance & Calibration ServicesThe contract entails providing quarterly on-site preventive maintenance, calibration, and safety testing services for the Illumina NovaSeq 6000 DNA sequencing instrument located at Fort Detrick, Maryland. These services must be performed using original equipment manufacturer (OEM)-certified technicians and tools to ensure proper upkeep and accuracy. The work supports the Naval Medical Research Center, a Department of Defense agency, and aligns with NAICS code 811211, which relates to equipment maintenance. The contract is classified as a subcontract with no set-aside status specified. The solicitation was posted on December 22, 2025, with a response deadline of December 31, 2026. Although the exact office location is unspecified, the place of performance is indicated as Silver Spring, Maryland, zip code 20910. This effort is critical to maintaining the operational readiness and reliability of high-precision DNA sequencing equipment essential to the agency's research objectives.

Consumer Electronics Repair and Maintenance

POSTED

DEADLINE